#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1096	CRP	633	633	99.37	CRP.l15.c17.ctg.1	1186	49.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	345	347	ACG	74;71;68	A;C;G	74;71;68	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1096	CRP	633	633	99.37	CRP.l15.c17.ctg.1	1186	49.7	0	.	p	.	0	T209S	NONSYN	625	627	ACT	885	887	TCT	43;38;36	T;C;T	43;38;36	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1440	1442	AGC	88;87;88	A,G;G;C	68,20;87;88	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	1	SNP	p	R234F	1	.	.	700	702	TTC	915	917	TTC	219;219;224	T;T;C	218;217;223	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1215	1217	CGT	179;184;186	C;G;T	177;184;184	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	0	HET	.	.	.	T180C	.	180	180	T	395	395	T	124	T,C	58,53	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	0	HET	.	.	.	C261T	.	261	261	C	476	476	C	154	C,T	86,62	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	4356	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1631	139.9	0	HET	.	.	.	T999C	.	999	999	T	1214	1214	T	172	T,C	101,70	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1188	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1852	34.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1625	1627	AAA	8;8;8	A;A;A	8;8;8	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2016	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c17.ctg.1	1909	56.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1342	1344	GAA	63;64;62	G;A;A	63;64;62	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	386	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	651	30.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	C990G	SNP	990	990	C	37	37	G	23	G	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	T1002A	SNP	1002	1002	T	49	49	A	32	A,C	31,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	A1003C	SNP	1003	1003	A	50	50	C	33	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	G1008C	SNP	1008	1008	G	55	55	C	34	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	C1011T	SNP	1011	1011	C	58	58	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	T1012C	SNP	1012	1012	T	59	59	C	33	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	C1023A	SNP	1023	1023	C	69	69	A	42	A	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	.1025G	INS	1025	1025	T	72	72	G	46	G	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	88	88	G	44	G	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	25.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	89	89	T	43	T	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	407	G	403	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	390	C	387	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	349	C,A	347,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	255	T	255	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	304	C	304	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	261	C	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	279	A	279	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	274	A	273	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	272	A	272	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	294	T	293	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	294	C	293	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	287	C	286	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	292	A	292	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	292	G	291	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	306	C	304	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	316	T	315	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	386	G	384	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	400	G	398	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	411	T	410	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	272	T	271	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	257	G	257	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	228	C	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	213	A	211	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	168	C	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	156	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	19	A	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	20	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	22	G	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	29	C	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	124	G	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	129	T	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	295.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	276	C	276	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	32	G	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	A1004G	SNP	1004	1004	A	54	54	G	47	G	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	47	T	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	C1023A	SNP	1023	1023	C	73	73	A	62	A	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	T1024A	SNP	1024	1024	T	74	74	A	62	A,T	60,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	56	G	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5886	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c30.ctg.4	143	31.6	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	54	T	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1570	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1337	60.9	0	.	p	.	0	H2R	NONSYN	4	6	CAT	213	215	CGT	39;40;41	C;G,T;T	39;37,1;41	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1570	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1337	60.9	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1056	1058	GGC	61;59;58	G;G;C	61;58;58	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2298	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2134	57.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	236	238	AGC	17;16;20	A;G;C	17;16;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2298	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2134	57.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	638	640	CTA	44;47;47	C;T;A	44;47;47	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2298	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2134	57.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1157	1159	CAA	114;113;117	C;A,G;A	111;111,1;116	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2298	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2134	57.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1256	1258	GGT	111;111;111	G;G;T	111;111;111	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2298	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2134	57.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1826	1828	GTT	33;33;30	G;T;T	33;33;30	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	846	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1635	27.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	585	587	GAA	29;30;29	G;A;A	29;30;28	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	846	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1635	27.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	765	767	ACC	20;20;18	A;C;C	20;20;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	846	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1635	27.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	885	887	ACT	29;29;28	A;C;T	29;29;28	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	846	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1635	27.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1275	1277	ATC	22;23;23	A;T;C	22;23;23	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1044	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1388	40.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	523	3470	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3689	50.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	572	574	ATC	50;48;49	A;T;C	50;48;49	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	523	3470	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3689	50.5	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1964	1966	AGC	68;68;67	A;G;C	68;68;67	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	523	3470	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3689	50.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2285	2287	AAG	31;31;33	A;A;G	31;31;33	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	523	3470	acrD	3114	92	97.83	acrD.l6.c30.ctg.2	139	0.4	0	.	p	.	0	W893S	NONSYN	2677	2679	TGG	110	112	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1670	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1638	54.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	315	317	GTC	22;21;17	G;T;C	22;21;17	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1670	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1638	54.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1056	1058	TGC	83;83;85	T;G;C	81;82;85	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	421	421	T	47	T,A	45,1	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	727	729	GAC	52;55;55	G;A;C	52;55;55	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1003	1005	TTA	37;38;38	T;T;A	37;38;38	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2080	2082	AAT	71;70;69	A;A;T	71;70;69	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2194	2196	AGT	60;64;64	A;G;T	60;64;64	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2593	2595	GTG	29;29;28	G;T;G	29;27;28	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3994	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3504	60.7	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3148	3150	AAG	62;62;63	A;A;G	62;61;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	832	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1110	40.3	1	SNP	p	R45C	0	.	.	133	135	CGC	334	336	CGC	76;77;76	C;G;C	75;77;76	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	770	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1075	38.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	189	191	TTC	34;34;35	T;T;C	34;34;35	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	770	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1075	38.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	453	455	GGG	49;46;49	G;G;G	49;45;48	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	896	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1202	40.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	625	627	CTT	80;81;81	C;T;T	80;81;81	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4092	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3097	71.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2107	2109	GCA	97;98;100	G;C;A	96;98;100	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4092	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3097	71.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2368	2370	ACC	98;93;94	A;C;C	98;92;93	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4092	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3097	71.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2677	2679	GCC	66;65;64	G;C;C,G	66;62;63,1	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	333	335	GCT	14;14;15	G;C;T	14;14;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	453	455	GAG	9;9;9	G;A;G	9;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	489	491	TGC	15;16;16	T;G;C	15;16;16	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	I150V	NONSYN	448	450	ATT	672	674	GTT	40;40;40	G;T;T	40;40;40	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	R200H	NONSYN	598	600	CGC	822	824	CAC	43;44;45	C;A;C	43;44;45	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1107	1109	ATG	53;55;55	A;T;G	53;55;52	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1634	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2427	36.1	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2103	2105	CGC	40;40;39	C;G;C	40;40;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	628	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1273	26.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	920	922	ACC	12;12;12	A;C;C	12;11;12	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	628	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1273	26.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	932	934	TCG	17;20;19	T;C;G,A	17;20;18,1	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	742	baeR	723	723	97.79	baeR.l6.c4.ctg.1	1205	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1286	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1869	36.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1317	1319	AAA	10;11;11	A;A;A	9;11;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1286	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1869	36.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1329	1331	GAG	12;13;12	G;A;G	12;11;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1286	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1869	36.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1335	1337	CAC	12;12;13	C;A;C	11;12;13	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1286	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1869	36.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1389	1391	GAG	25;25;24	G;A;G	24;25;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	3326	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1924	92.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	2032	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1255	87.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	810	cysB	975	975	99.38	cysB.l6.c30.ctg.1	1372	31.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1326	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1665	42.7	0	.	p	.	0	W42C	NONSYN	124	126	TGG	382	384	TGT	19;18;18	T;G;T	19;18;18	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1326	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1665	42.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	913	915	GTC	80;78;79	G;T;C	78;76;77	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	2088	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	2024	55.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1470	emrD	1191	1191	98.57	emrD.l15.c17.ctg.1	1662	47.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	837	839	AGC	36;36;35	A;G;C	35;35;34	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	36	emrE_1	333	91	96.7	emrE_1.l15.c4.ctg.1	92	10.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	884	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1528	31.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	755	757	AGG	25;26;26	A;G;G	25;26;26	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	884	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1528	31.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1145	1147	GAC	20;20;20	G;A;C	20;20;20	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	756	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1002	40.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1334	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2057	34.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	530	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1094	26.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	410	412	CTG	32;35;37	C;T;G	32;34;37	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	179	181	AAA	12;12;11	A;A;A	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	914	916	CAT	29;30;29	C;A,C;T	28;29,1;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	968	970	CAT	37;38;38	C;A;T	37;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	986	988	AGA	43;43;44	A;G;A	43;43;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1001	1003	AAT	47;46;46	A;A;T	47;46;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1148	1150	TCC	30;32;30	T,G;C;C	29,1;32;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1313	1315	ATT	25;25;27	A;T;T	25;25;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1334	1336	GAT	22;24;26	G;A;T	21;24;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1448	1450	GTT	44;42;43	G;T;T	44;42;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1733	1735	CAC	50;50;51	C;A;C	50;50;51	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	2476	97.86	evgS.l15.c17.ctg.1	2650	42.4	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2471	2473	AAC	18;18;18	A;A;C	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	T38I	NONSYN	112	114	ACA	272	274	ATA	15;14;14	A;T;A	15;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	L42V	NONSYN	124	126	CTA	284	286	GTA	23;23;24	G;T;A	23;23;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	437	439	ACG	33;32;32	A;C;G	33;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	500	502	GAA	43;43;43	G;A;A	43;43;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	539	541	GCT	40;38;38	G;C;T	40;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	557	559	GAT	29;29;28	G;A;T	29;29;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	644	646	TCA	29;28;28	T;C;A	29;28;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	773	775	CAG	22;21;21	C;A;G	22;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	911	913	GTT	22;21;22	G;T;T	22;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1067	1069	GAT	15;15;14	G;A;T	15;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2782	evgS	3594	1087	96.96	evgS.l15.c17.ctg.2	1247	29.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1235	1237	AAT	7;7;7	A;A;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1016	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1307	41.8	1	SNP	p	P64H	0	.	.	190	192	CCA	413	415	CCA	77;77;77	C;C;A	77;77;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1016	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1307	41.8	1	SNP	p	P64S	0	.	.	190	192	CCA	413	415	CCA	77;77;77	C;C;A	77;77;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1016	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1307	41.8	1	SNP	p	P64A	0	.	.	190	192	CCA	413	415	CCA	77;77;77	C;C;A	77;77;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1016	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1307	41.8	1	SNP	p	P64L	0	.	.	190	192	CCA	413	415	CCA	77;77;77	C;C;A	77;77;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1016	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1307	41.8	1	SNP	p	P64R	0	.	.	190	192	CCA	413	415	CCA	77;77;77	C;C;A	77;77;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	556	gadE	528	528	100.0	gadE.l15.c4.ctg.1	966	30.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	E54D	NONSYN	160	162	GAA	3	5	GAT	3;5;5	G;A;T	1;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	I88M	NONSYN	262	264	ATA	105	107	ATG	5;5;5	A;T;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	108	110	CCG	5;5;5	C;C;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	D100E	NONSYN	298	300	GAC	141	143	GAA	4;4;4	G;A;A	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	P101S	NONSYN	301	303	CCC	144	146	TCC	4;4;4	T;C;C	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	R102G	NONSYN	304	306	CGG	147	149	GGG	4;5;6	G;G;G	4;5;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	168	gadW	729	501	94.21	gadW.l6.c4.ctg.1	501	13.0	0	.	p	.	0	K110N	NONSYN	328	330	AAA	171	173	AAT	6;6;6	A;A;T	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	692	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1198	30.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	385	387	TTA	34;34;33	T;T;A	34;34;33	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	692	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1198	30.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	463	465	ATT	28;28;26	A;T;T	28;28;26	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	692	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1198	30.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	964	966	GGA	23;26;24	G;G;A	22;26;24	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	692	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1198	30.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	970	972	CCG	27;27;26	C;C;G	26;27;26	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2292	2294	GAA	59;60;64	G;A;A	59;58;64	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	S83W	0	.	.	247	249	TCG	507	509	TCG	65;65;65	T;C;G	65;64;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	S83I	0	.	.	247	249	TCG	507	509	TCG	65;65;65	T;C;G	65;64;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	S83L	0	.	.	247	249	TCG	507	509	TCG	65;65;65	T;C;G	65;64;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	519	521	GAC	66;67;66	G;A;C	63;64;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	D87H	0	.	.	259	261	GAC	519	521	GAC	66;67;66	G;A;C	63;64;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	D87V	0	.	.	259	261	GAC	519	521	GAC	66;67;66	G;A;C	63;64;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	D87G	0	.	.	259	261	GAC	519	521	GAC	66;67;66	G;A;C	63;64;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3444	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3187	58.1	1	SNP	p	D87N	0	.	.	259	261	GAC	519	521	GAC	66;67;66	G;A;C	63;64;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136L	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136S	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136I	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136E	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136H	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136G	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3410	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2912	62.9	1	SNP	p	R136C	0	.	.	406	408	CGC	632	634	CGC	69;67;65	C;G;C,A	69;67;63,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	498	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1028	26.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	417	419	CCG	42;45;45	C;C;G	42;45;45	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	498	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1028	26.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	570	572	GCC	31;31;31	G;C;C	31;31;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1216	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1447	45.0	0	.	p	.	0	P9S	NONSYN	25	27	CCA	237	239	TCA	39;41;46	T;C;A	39;41;46	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	458	marA	384	384	99.74	marA.l15.c4.ctg.1	946	25.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	577	579	AGC	18;19;19	A;G;C	18;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	679	681	CAT	4;3;5	C;A;T	4;3;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	V45E	0	.	.	133	135	GTG	403	405	GTG	31;30;29	G;T;G	31;28;29	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	I49S	0	.	.	145	147	ATC	415	417	ATC	25;25;25	A;T;C	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	A70T	0	.	.	208	210	GCA	478	480	GCA	17;17;17	G;C;A	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R73C	0	.	.	217	219	CGT	487	489	CGT	17;17;16	C;G;T	17;17;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R73S	0	.	.	217	219	CGT	487	489	CGT	17;17;16	C;G;T	17;17;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R77L	0	.	.	229	231	CGC	499	501	CGC	15;15;15	C;G;C	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R77C	0	.	.	229	231	CGC	499	501	CGC	15;15;15	C;G;C	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	L78M	0	.	.	232	234	CTG	502	504	CTG	14;14;14	C;T;G	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R94H	0	.	.	280	282	CGC	550	552	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	R94S	0	.	.	280	282	CGC	550	552	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	224	marR	435	435	97.7	marR.l6.c30.ctg.1	838	14.3	1	SNP	p	V96E	0	.	.	286	288	GTA	556	558	GTA	19;19;18	G;T;A	19;19;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	54	56	TTC	7;6;7	T;T;C	7;6;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	141	143	ATC	12;11;10	A;T;C	11;10;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	159	161	GCC	9;9;9	G;C;C	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	162	164	GTG	11;11;14	G;T;G	11;11;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	189	191	GAT	20;21;21	G;A;T	20;21;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	210	212	ACC	21;21;21	A;C;C	21;21;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	237	239	TTA	19;19;19	T;T;A	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	378	380	CAG	53;51;49	C;A;G	53;51;49	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	417	419	GCC	31;31;31	G;C;C	31;31;31	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	522	524	GCG	32;32;31	G;C;G	30;31;31	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	726	728	GTT	23;25;26	G;T;T	16;23;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	816	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1491	28.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	888	888	C	23	C	23	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	926	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1631	30.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	257	257	G	25	G	25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	926	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1631	30.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	314	316	CAG	19;19;18	C;A;G	19;18;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	926	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1631	30.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	464	466	ATC	26;26;25	A;T;C	25;26;25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	926	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1631	30.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	512	514	ATG	15;16;17	A;T;G	15;16;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	926	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1631	30.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	605	607	ACC	36;35;33	A;C;C	35;35;33	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1965	1967	ACC	69;67;64	A;C;C	69;66;64	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2358	2360	CAA	34;33;33	C;A;A	33;33;33	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2526	2528	ATT	42;41;40	A;T;T	42;40;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2610	2612	GTT	46;47;50	G;T;T	45;46;50	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2718	2720	GAG	42;39;38	G;A;G	42;39;38	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2946	2948	ATG	40;41;43	A;T;G	40;41;43	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3510	55.4	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3081	3083	GAT	45;46;50	G;A;T	45;46;50	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3114	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3402	48.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	339	341	ATG	26;26;27	A;T;G	26;25;27	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3114	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3402	48.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	825	827	ATC	51;54;58	A;T;C	50;54;57	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3114	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3402	48.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3141	3143	CAC	6;6;6	C;A;C	6;6;6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1470	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1897	41.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	212	214	GAA	19;18;18	G;A;A	19;18;18	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1470	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1897	41.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	881	883	GCG	56;57;59	G;C,T;G	56;56,1;59	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1470	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1897	41.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1223	1225	ATC	59;60;61	A;T;C	59;60;61	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1470	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1897	41.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1526	1528	TTT	54;55;53	T;T;T	54;55;53	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1914	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1656	62.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4512	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3666	66.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1155	1157	ACC	53;53;52	A;C,A;C	53;46,4;52	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4512	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3666	66.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2397	2399	GAC	85;86;85	G;A;C	84;85;84	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1330	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1589	37.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	664	666	ATC	37;37;39	A;T;C	37;37;39	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1330	mdtG	1227	177	99.44	mdtG.l15.c30.ctg.3	186	31.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	9;11;11	G;G;A	9;11;11	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1116	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1617	36.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	642	644	TGT	51;52;52	T;G;T	51;51;52	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1116	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1617	36.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1212	1214	TTG	31;30;30	T;T;G	31;30;30	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1116	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1617	36.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1422	1424	ACG	8;8;7	A;C;G	8;8;7	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1570	mdtL	1176	1176	98.21	mdtL.l6.c30.ctg.1	1763	48.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	838	840	TCC	45;45;47	T;C;C	43;44;47	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1000	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1601	33.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	646	648	ATT	32;32;31	A;T;T	32;32;31	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	230	232	ATG	26;26;27	A;T;G	25;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	296	298	ATC	39;38;38	A;T;C	39;38;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	545	547	CGC	75;75;72	C;G;C	72;75;69	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	911	913	AGC	52;52;52	A;G;C	52;51;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1112	1114	GTG	47;48;48	G;T;G	47;44;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1175	1177	AAC	21;20;21	A;A;C	20;19;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1220	1222	GTC	48;49;51	G;T,C;C	48;47,1;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1250	1252	ATA	80;78;78	A;T;A	80;77;77	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1358	1360	TCT	47;48;49	T;C;T	47;48;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1745	1747	GCG	64;64;63	G;C;G	61;62;62	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2698	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2479	58.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1958	1960	ATC	54;55;57	A;T;C	54;55;56	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	458	458	T	74	T	73	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	641	643	GCG	38;39;38	G;C;G	36;37;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	815	817	ACC	47;47;48	A;C;C	47;47;48	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	887	889	CGC	56;57;56	C,G;G;C,T	55,1;56;55,1	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1004	1006	GCT	49;49;52	G;C;T	46;48;51	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1088	1090	AAA	32;30;29	A;A;A	32;30;29	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1106	1108	CGA	38;37;36	C;G;A	38;37;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1271	1273	GCC	27;27;26	G;C,A;C	27;26,1;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1283	1285	GAT	30;32;33	G;A;T	30;32;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1556	mdtP	1467	1467	97.89	mdtP.l6.c30.ctg.1	2007	41.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1700	1702	GCT	9;8;8	G;C;T	9;8;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3778	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3926	51.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1530	1532	AAG	45;46;46	A;A;G	44;46;46	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3778	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3926	51.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2607	2609	CTG	56;56;55	C;T;G	56;56;55	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	208	mgrB	144	144	100.0	mgrB.l15.c17.ctg.3	164	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2426	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	2186	59.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1061	1063	AAC	53;53;56	A;A;C	53;52;56	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2426	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	2186	59.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1607	1609	ATA	88;88;85	A;T;A	86;87;84	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1886	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1768	57.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1364	1366	GAT	68;69;70	G;A;T	68;69;70	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1886	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1768	57.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1367	1369	CTG	71;73;74	C;T;G	71;73;74	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	264	266	TGT	35;35;34	T,C;G;T	34,1;35;34	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	534	536	ACC	44;45;45	A;C;C	44;45;44	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	744	746	GAC	23;22;23	G;A;C	23;22;23	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	1	SNP	p	R15C	0	.	.	43	45	CGC	228	230	CGC	45;42;43	C;G;C	45;42;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	1	SNP	p	S33R	0	.	.	97	99	AGC	282	284	AGC	31;32;31	A;G;C	30;32;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	1	SNP	p	G131D	0	.	.	391	393	GGC	576	578	GGC	28;27;25	G;G;C	28;27;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	1	SNP	p	R203L	0	.	.	607	609	CGT	792	794	CGT	28;28;30	C;G;T	28;28;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	584	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1169	26.7	1	SNP	p	R203C	0	.	.	607	609	CGT	792	794	CGT	28;28;30	C;G;T	28;28;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1624	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1511	57.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1158	1160	GAG	62;61;62	G;A;G	62;61;62	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1624	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1511	57.4	1	SNP	p	G141D	0	.	.	421	423	GGT	645	647	GGT	89;88;87	G;G;T	89;88;87	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1624	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1511	57.4	1	SNP	p	G141E	0	.	.	421	423	GGT	645	647	GGT	89;88;87	G;G;T	89;88;87	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1624	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1511	57.4	1	SNP	p	R154A	0	.	.	460	462	CGT	684	686	CGT	97;101;100	C;G;T	97;101;100	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1624	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1511	57.4	1	SNP	p	R154D	0	.	.	460	462	CGT	684	686	CGT	97;101;100	C;G;T	97;101;100	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3394	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2730	66.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1899	1901	TCG	85;84;85	T;C;G	82;84;84	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3394	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2730	66.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2514	2516	AAC	65;65;65	A;A;C	65;65;65	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3394	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2730	66.9	1	SNP	p	A85T	0	.	.	253	255	GCG	528	530	GCG	59;57;55	G;C;G,T	58;55;53,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3394	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2730	66.9	1	SNP	p	D111H	0	.	.	331	333	GAT	606	608	GAT	52;52;54	G;A;T	50;52;53	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3394	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2730	66.9	1	SNP	p	S129P	0	.	.	385	387	TCC	660	662	TCC	59;58;57	T;C;C	59;58;56	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	2096	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2445	46.1	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1698	1700	GAT	90;92;94	G;A;T	90;92;94	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2046	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1870	58.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1307	1309	GAT	61;61;62	G;A;T	60;61;62	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	V146F	0	.	.	436	438	GTT	673	675	GTT	94;91;91	G;T;T	94;91;91	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1774	1776	CAG	100;101;99	C;A;G	99;100;98	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1774	1776	CAG	100;101;99	C;A;G	99;100;98	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1813	1815	CAC	83;84;84	C;A;C	83;84;84	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1822	1824	CGT	76;77;78	C;G;T	76;77;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1822	1824	CGT	76;77;78	C;G;T	76;77;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1828	1830	TCC	78;73;72	T;C;C	78;73;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1834	1836	CTC	68;69;70	C;T;C	67;68;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1924	1926	ACC	84;83;84	A;C;C	83;83;84	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1927	1929	CCT	83;83;81	C;C;T	82;83;81	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6908	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4543	81.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2296	2298	CGT	160;157;152	C;G;T	159;156;149	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	.	n	.	0	A226G	SNP	226	226	A	362	362	G	626	G,C	621,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	1	SNP	n	A794T	0	.	.	794	794	A	930	930	A	466	A	461	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	1	SNP	n	A794G	0	.	.	794	794	A	930	930	A	466	A	461	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	1	SNP	n	G926A	0	.	.	926	926	G	1062	1062	G	489	G,T	487,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	1	SNP	n	G926T	0	.	.	926	926	G	1062	1062	G	489	G,T	487,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	1	SNP	n	G926C	0	.	.	926	926	G	1062	1062	G	489	G,T	487,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	T90C	.	90	90	T	226	226	T	421	T,C	275,145	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	A250T	.	250	250	A	386	386	A	586	A,T	391,190	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	G474A	.	474	474	G	610	610	G	538	G,A	404,128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	A253T	.	253	253	A	389	389	A	564	A,T	372,190	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	A79G	.	79	79	A	215	215	A	435	A,G	286,146	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	C719T	.	719	719	C	855	855	C	405	C,T	253,147	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	T273A	.	273	273	T	409	409	T	504	T,A	325,169	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1137	448.9	0	HET	.	.	.	C183T	.	183	183	C	319	319	C	462	C,T	325,136	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	613.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	362	A	360	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	613.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	362	A	360	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	613.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	362	A	360	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	141	100.0	rrsB+.l15.c17.ctg.5	141	105.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	203	A,G	200,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	210	C,T	208,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	209	C	207	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	206	G	206	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	204	G	204	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	17160	rrsB+	1542	143	95.14	rrsB+.l15.c17.ctg.6	143	104.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	178	T	178	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	818	soxR	465	465	100.0	soxR.l15.c4.ctg.1	854	51.1	1	SNP	p	R20H	0	.	.	58	60	CGC	243	245	CGC	101;98;100	C;G;C	100;98;100	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	818	soxR	465	465	100.0	soxR.l15.c4.ctg.1	854	51.1	1	SNP	p	G121D	0	.	.	361	363	GGT	546	548	GGT	67;67;68	G;G;T	67;67;67	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	560	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	922	32.7	1	SNP	p	A12S	0	.	.	34	36	GCA	304	306	GCA	70;71;72	G;C;A	70;71;72	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	3076	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1309	125.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	539	3242	APH_6__Id+	837	837	99.88	APH_6__Id+.l15.c30.ctg.1	1381	125.6	0	.	p	.	0	E47K	NONSYN	139	141	GAA	395	397	AAA	111;109;106	A;A;A	111;108;105	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	1880	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1320	76.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2276	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2036	60.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
